MDA-MB-231细胞专用培养基(L15)

一键复制产品信息

参考文献

• PRMT5 reduces immunotherapy efficacy in triple-negative breast cancer by methylating KEAP1 and inhibiting ferroptosis (2023-06-01)

  作者：Zhe Wang:1.Department of Thyroid, Breast and Vascular Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, People's Republic of China. ; 2.The State Key Laboratory of Cancer Biology, Department of Biochemistry and Molecular Biology, Fourth Military Medical University, Xi'an, Shaanxi, People's Republic of China. ; Ruolei Li:1.Department of Thyroid, Breast and Vascular Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, People's Republic of China. ; 2.The State Key Laboratory of Cancer Biology, Department of Biochemistry and Molecular Biology, Fourth Military Medical University, Xi'an, Shaanxi, People's Republic of China. ; Niuniu Hou:1.Department of Thyroid, Breast and Vascular Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, People's Republic of China. ; 2.Department of General Surgery, Eastern Theater Air Force Hospital of PLA, Nanjing, Jiangsu, People's Republic of China. ; Juliang Zhang:1.Department o

  期刊：PRMT5 reduces immunotherapy efficacy in triple-negative breast cancer by methylating KEAP1 and inhibiting ferroptosis

  DOI：10.1136/jitc-2023-006890

  影响因子 ：10.9

  引用产品： MDA-MB-231 细胞 ,  MDA-MB-231细胞专用培养基 (L15) ,  4T1 细胞 ,  4T1细胞专用培养基

• CircEGFR reduces the sensitivity of pirarubicin and regulates the malignant progression of triple-negative breast cancer via the miR-1299/EGFR axis (2023-06-09)

  作者：Jiulong Ma:1.Department of Experimental Pharmacology and Toxicology, School of Pharmaceutical Sciences, Jilin University, 1266 Fujin Road, Changchun, Jilin 130021, China. ; Chen Chen:1.Department of Pharmacology, School of Pharmaceutical Sciences, Jilin University, 1266 Fujin Road, Changchun, Jilin 130021, China. ; Zhimin Fan:1.General Surgery Center, Department of Breast Surgery, The First Hospital of Jilin University, Changchun, Jilin 130021, China. ; Yang Zhang:1.Department of Rehabilitation Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China. ; Jiahua Ji:1.Department of Experimental Pharmacology and Toxicology, School of Pharmaceutical Sciences, Jilin University, 1266 Fujin Road, Changchun, Jilin 130021, China. ; Dexian Wei:1.Department of Experimental Pharmacology and Toxicology, School of Pharmaceutical Sciences, Jilin University, 1266 Fujin Road, Changchun, Jilin 130021, China. ; Fan Zhang:1.General Surgery Center, Department of Breast Surgery, The Firs

  期刊：CircEGFR reduces the sensitivity of pirarubicin and regulates the malignant progression of triple-negative breast cancer via the miR-1299/EGFR axis

  DOI：10.1016/j.ijbiomac.2023.125295

  影响因子 ：8.2

  引用产品： MCF 10A 细胞 ,  BT-474 [BT474] 细胞 ,  SK-BR-3 [SKBR3] 细胞 ,  MDA-MB-231 细胞 ,  MCF 10A细胞专用培养基 ,  BT-474 [BT474]细胞专用培养基 ,  SK-BR-3 [SKBR3]细胞专用培养基 ,  MDA-MB-231细胞专用培养基 (L15)

• A novel feedback regulated loop of circRRM2-IGF2BP1-MYC promotes breast cancer metastasis (2023-03-25)

  作者：Ran Hao:1.Institutes of Health Research, Hebei Medical University, Shijiazhuang, Hebei, China. ; Lei Zhang:1.Institutes of Health Research, Hebei Medical University, Shijiazhuang, Hebei, China. ; Yangming Si:1.School of Physical Science and Technology, Inner Mongolia University, Hohhot, Inner Mongolia, China. ; Peng Zhang:1.Institutes of Health Research, Hebei Medical University, Shijiazhuang, Hebei, China. ; 2.Department of Military Nursing, NCO School, Army Medical University, Shijiazhuang, Hebei, China. ; Yipeng Wang:1.Institutes of Health Research, Hebei Medical University, Shijiazhuang, Hebei, China. ; Bangchao Li:1.Department of Breast Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China. ; Jie Hu:1.Department of Science and Technology, Hebei Medical University, Shijiazhuang, Hebei, China. Hujie@hebmu.edu.cn. ; Yixin Qi:1.Department of Breast Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China. qiyixin@hebmu.ed

  期刊：A novel feedback regulated loop of circRRM2-IGF2BP1-MYC promotes breast cancer metastasis

  DOI：10.1186/s12935-023-02895-w

  影响因子 ：5.8

  引用产品： MCF 10A 细胞 ,  BT-474 [BT474] 细胞 ,  BT-549 细胞 ,  MCF7 [MCF-7] 细胞 ,  MDA-MB-231 细胞 ,  MDA-MB-231 细胞 ,  MDA-MB-453 细胞 ,  MDA-MB-453 细胞 ,  T-47D 细胞 ,  MCF 10A细胞专用培养基 ,  BT-474 [BT474]细胞专用培养基 ,  BT-549细胞专用培养基 ,  MCF7 [MCF-7]细胞专用培养基 ,  MDA-MB-231细胞专用培养基 (L15) ,  MDA-MB-231细胞专用培养基 (DMEM) ,  MDA-MB-453细胞专用培养基 (L15)

• Leveraging senescence-oxidative stress co-relation to predict prognosis and drug sensitivity in breast invasive carcinoma (2023-08-04)

  作者：Yinghui Ye:1.Department of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, China. ; Yulou Luo:1.Department of Breast Surgery, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, China. ; Tong Guo:1.Department of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, China. ; Chenguang Zhang:1.Department of Breast Surgery, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, China. ; Yutian Sun:1.Department of Medical Oncology, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China. ; Anping Xu:1.Department of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, China. ; Ling Ji:1.Department of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, China. ; Jianghua Ou:1.Department of Breast Surgery, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, China. ; Shang Ying Wu:1.Depa

  期刊：Leveraging senescence-oxidative stress co-relation to predict prognosis and drug sensitivity in breast invasive carcinoma

  DOI：10.3389/fendo.2023.1179050

  影响因子 ：5.2

  引用产品： MCF7 [MCF-7] 细胞 ,  BT-20 细胞 ,  MDA-MB-231 细胞 ,  HCC1806 细胞 ,  HCC1937 细胞 ,  MCF7 [MCF-7]细胞专用培养基 ,  BT-20细胞专用培养基 ,  MDA-MB-231细胞专用培养基 (L15) ,  HCC1806细胞专用培养基 ,  HCC1937细胞专用培养基

• Prognosis stratification of patients with breast invasive carcinoma based on cysteine metabolism-disulfidptosis affinity (2023-07-08)

  作者：Yuting Zhang:1.Department of Breast Surgery, The First Affiliated Hospital, Jinan University, Guangzhou, 510000, China. ; Yinghui Ye:1.Department of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, 518000, China. ; Anping Xu:1.Department of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, 518000, China. ; Yulou Luo:1.Department of Breast Surgery, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, 830000, China. ; Yutian Sun:1.Department of Medical Oncology, School of Medicine, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, 610000, China. ; Wei Zhang:1.Department of Breast Surgery, The First Affiliated Hospital, Jinan University, Guangzhou, 510000, China. zhangwei@jnu.edu.cn. ; Ling Ji:1.Department of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, 518000, China. 1120303921@qq.com. ;

  期刊：Prognosis stratification of patients with breast invasive carcinoma based on cysteine metabolism-disulfidptosis affinity

  DOI：10.1007/s00432-023-05028-y

  影响因子 ：3.6

  引用产品： MCF7 [MCF-7] 细胞 ,  MCF7 [MCF-7]细胞专用培养基 ,  BT-20 细胞 ,  BT-20细胞专用培养基 ,  MDA-MB-231 细胞 ,  MDA-MB-231细胞专用培养基 (L15) ,  MDA-kb2 细胞 ,  MDA-kb2细胞专用培养基 (L15) ,  HCC1937 细胞 ,  HCC1937细胞专用培养基

• Silencing of long noncoding RNA MIAT inhibits the viability and proliferation of breast cancer cells by promoting miR-378a-5p expression (2023-04-03)

  作者：Chao Yan:1.Medical Laboratory, The Affiliated Huai'an Hospital of Xuzhou Medical University and The Second People's Hospital of Huai'an, Huai'an 223003, Jiangsu, China. ; Yue Jin:1.Medical Laboratory, The Affiliated Huai'an Hospital of Xuzhou Medical University and The Second People's Hospital of Huai'an, No. 62, Huaihai South Road, Qingjiangpu District, Huai'an 223003, Jiangsu, China. ;

  期刊：Silencing of long noncoding RNA MIAT inhibits the viability and proliferation of breast cancer cells by promoting miR-378a-5p expression

  DOI：10.1515/med-2023-0676

  影响因子 ：2.1

  引用产品： MDA-MB-231细胞专用培养基 (L15) ,  SK-BR-3 [SKBR3]细胞专用培养基 ,  BT-20细胞专用培养基 ,  MDA-MB-436细胞专用培养基 (L15)

• Low Dose of Paclitaxel Combined with XAV939 Attenuates Metastasis, Angiogenesis and Growth in Breast Cancer by Suppressing Wnt Signaling (2008-09-20)

  作者：Dattatrya Shetti:1.School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, China. ; Bao Zhang:1.School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, China. ; Conghui Fan:1.School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, China. ; Canlong Mo:1.School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, China. ; Bae Hoon Lee:1.Wenzhou Institute of Biomaterials and Engineering, University of CAS, Wenzhou 325011, China. bhlee@wibe.ac.cn. ; 2.School of Biomedical Engineering, School of Ophthalmology & Optometry, Wenzhou Medical University, Wenzhou 325027, China. bhlee@wibe.ac.cn. ; Kun Wei:1.School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, China. weikun@scut.edu. ; 2.Wenzhou Institute of Biomaterials and Engineering, University of CAS, Wenzhou 325

  期刊：Low Dose of Paclitaxel Combined with XAV939 Attenuates Metastasis, Angiogenesis and Growth in Breast Cancer by Suppressing Wnt Signaling

  DOI：10.3390/cells8080892

  影响因子 ：6.0

  引用产品： MDA-MB-231细胞专用培养基 (L15) ,  MDA-MB-468细胞专用培养基 (L15) ,  BT-549细胞专用培养基 ,  MCF-7/DDP细胞专用培养基 ,  T-47D细胞专用培养基

点击展开收起列表